Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 4535-4538, September 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Honma, Y.
Right arrow Articles by Hozumi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honma, Y.
Right arrow Articles by Hozumi, M.

Hemin Enhances the Sensitivity of Erythroleukemia Cells to 1-ß-D-Arabinofuranosylcytosine by Both Activation of Deoxycytidine Kinase and Reduction of Cytidine Deaminase Activity1

Yoshio Honma2, Yuji Onozuka, Junko Okabe-Kado, Takashi Kasukabe and Motoo Hozumi

Department of Chemotherapy, Saitama Cancer Center Research Institute, Ina, Saitama-362, Japan

The sensitivity of human myelogenous leukemia cells to 1-ß-D-arabinofuranosylcytosine (ara-C) during induction of differentiation was examined. Treatment with hemin greatly increased the sensitivity of erythroid leukemia cells to ara-C. The enhancement of ara-C sensitivity by hemin was not as remarkable in nonerythroid leukemia cells. Hemin altered the metabolism of ara-C in human erythroleukemia K562 cells by reducing ara-C deaminase activity, increasing intracellular accumulation of ara-C, and activating the nucleoside kinases. These alterations may be involved in the enhancing effect of hemin on sensitivity of ara-C. These results suggest that some inducers of differentiation potentiate the antileukemic effect of ara-C on human erythroleukemia cells.

1 This work was supported by Grants-in-Aid for Cancer Research from the Ministery of Education, Science and Culture, and from the Ministry of Welfare and Health, Japan.

2 To whom requests for reprints should be addressed.

Received 1/ 2/91. Accepted 6/13/91.




This article has been cited by other articles:


Home page
Cancer Res.Home page
N. Niitsu, Y. Ishii, A. Matsuda, and Y. Honma
Induction of Differentiation of Acute Promyelocytic Leukemia Cells by a Cytidine Deaminase-resistant Analogue of 1-{beta}-D-Arabinofuranosylcytosine, 1-(2-Deoxy-2-methylene-{beta}-D-erythro-pentofuranosyl)cytidine
Cancer Res., January 1, 2001; 61(1): 178 - 185.
[Abstract] [Full Text]


Home page
BloodHome page
N. Niitsu, Y. Yamaguchi, M. Umeda, and Y. Honma
Human Monocytoid Leukemia Cells Are Highly Sensitive to Apoptosis Induced by 2'-Deoxycoformycin and 2'-Deoxyadenosine: Association With dATP-Dependent Activation of Caspase-3
Blood, November 1, 1998; 92(9): 3368 - 3375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.